BUSINESSFINANCIAL TIMES WORLD
Jardines signals pivot with $2.4bn Australian radiology deal
Jardines, a Hong Kong-based conglomerate, has acquired I-MED, an Australian radiology company, in a $2.4 billion deal. This marks the company's first acquisition since undergoing a strategic overhaul, signaling a potential business pivot.
Mentioned
Related Signal
Adjacent reporting
- Jardines agrees to buy Australian radiology leader in $2.4bn deal
- Jardine Is Said to Near Purchase of I-MED in $2.4 Billion Deal
- STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
- Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
- What's next after Warner Bros. shareholder approval of Paramount Skydance acquisition
- Itochu Takes Over AirLife’s Japan Sales in Healthcare Expansion